| Completed | 2 | 44 | Europe | Everolimus, Afinitor, Octreotide LAR, Sandostatine LAR | Radboud University Medical Center, Novartis | Polycystic Liver Disease | 07/12 | 07/12 | | |
NCT01188733: Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis |
|
|
| Completed | 1/2 | 39 | US | Long acting octreotide 10mg, Long-acting octreotide, Long acting Octreotide 30mg, Saline | Mayo Clinic | Cirrhosis, Portal Hypertension, Esophageal Varices | 07/00 | 12/00 | | |
